https://www.youtube.com/watch?v=rf7rw4RIx_Q
How Europe is Designing a Tax System You Can't Escape
(Taxes on unrealized fictional gains)
https://www.youtube.com/watch?v=rf7rw4RIx_Q
How Europe is Designing a Tax System You Can't Escape
(Taxes on unrealized fictional gains)
>444444
>https://www.coletividadeevolutiva.com/2025/09/cancer-parasita-toxocara-engana-medicos-fenbendazol-curando.html
Your Cancer May Be Only a Parasite: How Toxocara Fools Doctors and Why Fenbendazole May Be 'Curing' or Incurável
This study demonstrates that parasitic infestations can simulate advanced cancer in imaging tests, leading to erroneous diagnoses.
For decades, cancer was understood as a genetic disease characterized by the uncontrolled proliferation of abnormal cells. Conventional treatments — chemotherapy, radiotherapy and surgery — are based on this paradigm. However, a growing body of scientific evidence is raising a radical hypothesis: are most of the diagnoses of cancer, in truth, not genetic tumors, but rather infestations by microscopic parasites or persistent pathogens?
This theory, still controversial, has led to a growing number of studies demonstrating that antiparasitic medications, such as fenbendazole (a benzimidazole widely used in veterinary medicine) and antiparasitic/antimalaria, ivermectin, have demonstrated antiviral and anticancer effects in recent studies . It is reverted to what is clinically classified as cancer in experimental models. More intriguing: these effects occur with safety, low toxicity and multiple mechanisms of action against tumor cells.
This article explores that provocative hypothesis, analyzing recent evidence that cancer may, in many cases, be an organism's response to intracellular parasites or persistent pathogens — and that the success of antiparasitic drugs in cancer treatment may not be coincidence, but a scientific revelation of proportions revolutionary.
In 2024, a study published in the journal Diagnostics had an impact on the medical community by reporting an unusual case: a patient with colon cancer presented multiple lesions in the lungs and legs — typical of metastases. However, after detailed investigation, it was discovered that these lesions were not tumors, but rather granulomas caused by larvae of the Toxocara canis parasite, and we can see them together.
The article, entitled "Pulmonary and Liver Toxocariasis Mimicking Metastatic Tumors in a Patient with Colon Cancer" (Cheon & Yoo, 2024), demonstrates that parasitic infestations can simulate advanced cancer in imaging examinations, leading to erroneous diagnoses and unnecessary treatments.
This case raises a radical question: would it be possible that many cancer diagnoses, especially those with multiple lesions or rapid growth, would, in fact, have parasitic infestations or inflammatory responses to persistent pathogens?
Furthermore: if antiparasitic medications such as fenbendazole are being reversed or are classified as cancer, could it be that we are not testing a cure for parasites disguised as tumors?
The Toxocara Case: Fake Tumors That Deceive Specialists
In the study by Cheon and Yoo (2024) , a home with colon cancer in treatment showing pulmonary and hepatic nodules in tomographies. The initial diagnosis was generalized metastasis — a sign of terminal illness.
But, when analyzing the lesions, doctors will find granulomas with Toxocara larvae - a helminth parasite that causes visceral toxocaria. These larvae, migrating dyed hairs, induce chronic inflammation, nodule formation and alterations that perfectly imitate metastatic tumors.
🔑 Study conclusion:
"Lung and liver lesions caused by toxocariase can simulate metastases in cancer patients, leading to overdiagnoses and unnecessary aggressive treatments."
This case is not isolated. Toxocaríase was reported simulating cancer of the liver, lung, brain and lymphoma. The most surprising: treatment with antiparasitic agents such as albendazole or mebendazole frequently leads to complete resolution of the lesions.
And are Many "Cancers" Forem, na Verdade, Parasites?
He would get toxic as soon as he started. There are dozens of parasites, fungi and intracellular pathogens that can:
Form nodules or masses in organs
Inducir inflamação crônica
Stimulate angiogenesis (blood vessel formation)
Suppress the immune system
Alter cellular metabolism (Warburg effect)
Characteristics that, isolated, are identical to a malignant tumor.
Some researchers have speculated that:
Intracellular parasites (such as microsporids or helminth larvae) can inhabit tissues for years, avoiding detection.
Microbial biofilms can create tumor-like environments.
Chronic infections can trigger secondary mutations, but a serious primary cause or pathogen.
This scenario, or cancer, would be a consequence, not a cause — a body response to isolate an invader, such as a granuloma or inflammatory cyst.
If this is true, treating with chemotherapy would be like bombing a city to kill a hidden spy. The collateral damage is enormous. But treating with antiparasitics would be like eliminating the spy directly.
Fenbendazole: An Antiparasitic Drug that "Cures" Cancer?
Fenbendazole, a benzimidazole widely used in animals to treat intestinal worms, has been rediscovered as a potential anti-cancer agent. Although it is not approved for human use by the FDA or EMA, its effectiveness has been documented in more than ten recent scientific studies , as reviewed below:
2023 Jun – Movahedi et al – Reuse of benzimidazole antiparasitic drugs as selective anticancer chemotherapeutics
Apr 2023 – Chi-Son Chang et al – Anticancer effect of PLGA nanoparticles incorporated into fenbendazole on ovarian cancer
2023 Mar – Semkova et al – Redox-mediated anticancer activity of the antiparasitic drug fenbendazole in triplo-negative breast cancer cells
2023 Mar – Haebeen Jung et al – Differentiated cytotoxic effects of fenbendazole in EL-4 lymphoma cells of cammundongo and basal cells
2022 Sep – Deokbae Park et al – Anticancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells
2022 Jan – Li-wen Ren et al – Benzimidazóis simultaneous apoptose and pyroptose of human glioblastoma cells via cell cycle interruption
2020 Aug – Deok-Soo Son et al – The Potenciais Antitumorais dos Benzimidazole Anti-helmintics as Drug Reuse
2020 Jun – Yong Han et al – Involvement of oxygen-reactive species in the anticancer activity of fenbendazole, a benzimidazole anti-helmintic (leukemia)
2018 Aug – Dogra et al – Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
All these studies point to a clear picture: fenbendazole attacks cancer cells precisely as it kills parasites — without damaging healthy tissues.
But no clinical trial with fenbendazole is registered.
Because?
It is cheap, generic and not patentable
No profit for large pharmaceutical companies
It is sold as a veterinary medicine, making its regulation difficult
As an oncologist, Dr. William Makis observed :
"Fenbendazole is not intended to be used at all. In the world of cancer, it is the greatest impediment."
>after your death
after your death, your organs will be worthless.
if you only declared your organs to be extracted after your death, and a quack grabs them before your actual death, shouldn't that quack be liable?